Precision Behavioral Management (PBM) and Cognitive Control as a Potential Therapeutic and Prophylactic Modality for Reward Deficiency Syndrome (RDS): Is There Enough Evidence?

Margaret A. Madigan, Ashim Gupta, Abdalla Bowirrat, David Baron, Rajendra D. Badgaiyan, Igor Elman, Catherine A. Dennen, Eric R. Braverman, Mark S. Gold, Kenneth Blum

Research output: Contribution to journalComment/debate

5 Scopus citations

Abstract

This brief commentary aims to provide an overview of the available and relatively new precision management of reward deficiencies manifested as substance and behavioral disorders. Current and future advances, concepts, and the substantial evidential basis of this potential therapeutic and prophylactic treatment modality are presented. Precision Behavioral Management (PBM), conceptualized initially as Precision Addiction Management (PAM), certainly deserves consideration as an important modality for the treatment of impaired cognitive control in reward processing as manifested in people with neurobiologically expressed Reward Deficiency Syndrome (RDS).

Original languageEnglish
Article number6395
JournalInternational Journal of Environmental Research and Public Health
Volume19
Issue number11
DOIs
StatePublished - 1 Jun 2022

Keywords

  • Genetic Addiction Risk Severity (GARS) test
  • Restoregen ®
  • dopamine
  • hypodopaminergia
  • pro-dopamine regulation (KB220)

Fingerprint

Dive into the research topics of 'Precision Behavioral Management (PBM) and Cognitive Control as a Potential Therapeutic and Prophylactic Modality for Reward Deficiency Syndrome (RDS): Is There Enough Evidence?'. Together they form a unique fingerprint.

Cite this